Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 15.57x is 417% above its 5-year average of -4.91x, near the high end of its 5-year range (-61.35x–23.06x).
47.06% above its 12-month average of 10.59x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-06-30): 18.57x.
INTEREST COVERAGE RATIO
15.57x
INTEREST COVERAGE RATIO AVG TTM
10.59x
INTEREST COVERAGE RATIO AVG 3Y
-0.30x
INTEREST COVERAGE RATIO AVG 5Y
-4.91x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+47.06%
CURRENT VS 3Y AVG
+5365.00%
CURRENT VS 5Y AVG
+417.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
+375.82%
vs the sector median at left
Innovage Holding Corp.
Market Cap
$1.22B
Interest Coverage Ratio
15.57x
TTM Avg
10.59x
3Y Avg
-0.30x
5Y Avg
-4.91x
Market Cap
$1.21B
Interest Coverage Ratio
2.81x
TTM Avg
2.36x
3Y Avg
1.69x
5Y Avg
1.69x
Market Cap
$1.22B
Interest Coverage Ratio
N/A
TTM Avg
1.72x
3Y Avg
1.72x
5Y Avg
1.72x
Market Cap
$1.23B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.17B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.16B
Interest Coverage Ratio
-4.99x
TTM Avg
16.08x
3Y Avg
16.08x
5Y Avg
16.08x
Market Cap
$1.15B
Interest Coverage Ratio
2.05x
TTM Avg
1.65x
3Y Avg
1.11x
5Y Avg
0.98x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innovage Holding Corp. (INNV) | $1.22B | 15.57x | 10.59x | -0.30x | -4.91x |
| MannKind Corporation (MNKD)vs › | $1.21B | 2.81x | 2.36x | 1.69x | 1.69x |
| Cronos Group Inc. (CRON)vs › | $1.22B | N/A | 1.72x | 1.72x | 1.72x |
| Omada Health (OMDA)vs › | $1.22B | -4.72x | N/A | N/A | N/A |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.23B | N/A | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | N/A | N/A | N/A | N/A |
| Kardigan, Inc. (KARD)vs › | $1.27B | N/A | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.16B | -4.99x | 16.08x | 16.08x | 16.08x |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 2.05x | 1.65x | 1.11x | 0.98x |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.14B | N/A | N/A | N/A | N/A |
Interest Coverage
15.6x
Debt/Equity
0.37
Current Ratio
1.05
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 18.57x |
| 2026-03-31 | 23.06x |
| 2025-12-31 | 12.92x |
| 2025-09-30 | 7.15x |
| 2025-06-30 | -8.76x |
| 2025-03-31 | -8.76x |
| 2024-12-31 | -16.52x |
| 2024-09-30 | -3.94x |
| 2024-06-30 | -3.48x |
| 2024-03-31 | -5.67x |
| 2023-12-31 | -1.91x |
| 2023-09-30 | -16.21x |
| 2023-06-30 | -37.60x |
| 2023-03-31 | -20.17x |
| 2022-12-31 | -61.35x |
| 2022-09-30 | -27.53x |
| 2022-06-30 | -20.72x |
| 2022-03-31 | -9.41x |
| 2021-12-31 | 4.38x |
| 2021-09-30 | 21.32x |
| 2021-03-31 | -1.10x |
| 2020-12-31 | 3.13x |
| 2020-09-30 | -6.78x |
| 2020-06-30 | 6.05x |
| 2020-03-31 | 5.50x |
